HEALTH● ELEVATEDJul 30 · Jul 30, 2026, 10:00 AM
First-of-kind Guillain-Barré drug switches off part of immune system
New Scientist
A treatment that turns off the bit of the immune system that goes haywire in Guillain-Barré syndrome may be the first targeted therapy approved for the autoimmune condition
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH40m agoNCDHHS raises awareness of 988 Suicide and Crisis Lifelinewfdd.org · United StatesHEALTH1h agoMamdani releases records on toxic air in New York after 9/11 attacksAl Jazeera [en]HEALTH1h agoCommon painkiller use in early pregnancy linked to smaller ovaries and testesNew ScientistHEALTH3h agoCan cancer drugs treat osteoporosis and midlife weight gain ? purdueexponent.org · United States